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Abstract
Background: T wave alternans (TA) is a repolarisation phenomenon manifesting as a microvolt
beat to beat change in the amplitude of the T wave and ST segment. TA has been shown to be a
predictor of arrhythmic risk in unselected myocardial infarction populations. TA has not been used
to differentiate risk within the ischaemic cardiomyopathy population.
Methods: The subjects investigated comprised, Group 1: 7 stable patients with remote (>20
months) extensive myocardial scarring and no arrhythmic events (NYHA 3 and 4). Group2: 9 post
infarction patients with malignant arrhythmia and implantable defibrillator. During breath holding,
20 continuous QRST complexes from each patients X, Y and Z leads were digitally recorded. Time
domain, resultant absolute difference vectors (ATA), were calculated for alternate resultant T wave
sequences. Group differences between the magnitude and temporal distribution of mean ATAs and
their spectral and cross-spectral analysis were compared.
Results: Group 1 v Group 2 mean ATAs were 10.7 (7.17) v 11.7 (8.48) respectively, not significant.
Each group had a homogenous temporal distribution of ATAs. Both group's largest mean ATA
frequency components were between 0 to 25 Hz, the largest ATA component being at the DC
frequency. Cross spectral analysis showed no significant differences in group ATA frequency
content.
Conclusion:  The frequency content and microvolt magnitude of T wave alternans was not
significantly different in these two groups. The specificity of T wave alternans for differentiating
arrhythmic risk in post infarction scarring and heart failure needs investigation.
Background
T wave alternans (TA) is a repolarisation phenomenon
manifesting as a microvolt beat to beat change in ampli-
tude of the T wave and ST segment. The mechanism re-
sponsible for TA is a dynamic (beat to beat) variation of
the repolarisation sequence [1] due to either an alterna-
tion of action potential duration, frequently associated
with the long QT syndrome [2] or an alternation of the
time course of repolarisation [3] frequently associated
with ischaemia [4]. The alternation of time course and
multilevel distribution of electrical repolarisation activity
during ischaemia [4] cause the electrocardiographic man-
ifestation of TA in addition to alternating dispersion
through islands of partially and fully refractory tissue
which promote wavefront fractionation and vulnerability
to reentrant malignant arrhythmias (MA)[5,6].
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The earliest description of TA was made in 1910 by Lewis
[7]. Animal work by Hellerstein and Liebow showed a
mechanistic link between TA and arrhythmogenesis [8]
and recently the presence of TA has been recognised as be-
ing a harbinger of sudden death [9,10]. Rosenbaum et al
reported TA to be an independent prognosticator of vul-
nerability to arrhythmias predicted by electrophysiology
testing[11] and these findings were repeated by Armoun-
das and co-workers showing TA to be superior to signal
average electrocardiography as a predictor of malignant
ventricular arrhythmias in high risk populations [12]. TA
has demonstrated high sensitivities and specificities as a
predictor of arrhythmic risk in unselected myocardial inf-
arction populations [13] and idiopathic cardiomyopathy
[14] but TA has not been used to differentiate risk in the
ischaemic cardiomyopathy group.
The purpose of this pilot study was to use indices of abso-
lute micro voltage TA and the frequency content of alter-
nating T waves to assess the ability to differentiate post
infarction heart failure patients with significant substrates
for developing re-entrant MA but without arrhythmic
events, from those post infarction patients at most risk
from developing MA.
Materials and Methods
Approval was obtained from the local Ethics Committee
prior to performing the described research. The research
was conducted in accordance the Helsinki Declaration,
written informed consent was obtained from each patient
prior to collecting data. The study population consisted of
two groups of stable treated patients: Group 1 comprised
7 patients with extensive scarring secondary to myocardial
infarction and compensated treated left sided heart failure
with mean ejection fraction of 35%. The patient with the
most recent infarct event in this group occurred over 20
months prior to the study. No patient within group 1 sus-
tained a symptomatic arrhythmic event. Group 2 com-
prised 9 patients with a history of myocardial infarction
with a mean ejection fraction of 38%, a distant episode of
sustained ventricular tachycardia or aborted sudden death,
positive induction of sustained ventricular tachycardia
during an electrical stimulation study and a history of pro-
phylactic implantation of an automatic defibrillator.
20 sequential electrocardiographic complexes were re-
corded from X,Y and Z orthogonal leads on each resting
supine patient during a held half expiration breath with-
out straining. The ECG recordings were made using and
analog-to-digital converter (Powerlab), sampling at 1000
Hz. All the recorded signals were not filtered, because it
was intended to make inter-group statistical comparisons
in the frequency domain between the higher frequency
band of 80–500 Hertz, where there may exist representa-
tions of possible late potential repolarisation. As all signif-
icant non-noisy signals have been found to occur within a
0 to 40 Hertz pass-band [15], the recorded signals under-
went 40 Hertz low pass filtering prior to analysis in the
time domain.
For each lead on each patient, sequences of the alternate
ST-T waves were ensemble averaged over a 400 millisec-
ond duration using the positive or negative peak of the T
wave as the fiducial central point of data collection over
400 milliseconds, see figure 1. In leads where the T wave
was of low magnitude, the fiducial central point was taken
to occur as the point at an average of the times from the
peak QRS deflection to the fiducial T wave point in the
other clearly demarcated orthogonal leads. The vectors of
the squared magnitude of differences in ensemble aver-
aged time aligned alternating ST-T sequences were calcu-
lated on each lead from each patient. For each patient, the
resultant absolute difference vector (ATA) was calculated
as the square root of the summed squared differences be-
tween alternate ensemble averaged T waves for each X, Y
and Z vector. All calculations were performed using Math-
cad Professional signal processing software on a Acer Pen-
tium 2 PC. Comparisons were made between each mean
group ATA as well as between the intra and inter-group
means of vectors representing each third time interval of
the respective mean ATAs. The spectral content was calcu-
lated for each group mean ATA by digital fast Fourier algo-
rithm and cross spectral analysis was calculated between
each group mean ATA to assess differences in the frequen-
cy components within each group. In order to assess
group differences in the 80 to 500 Hertz frequency band,
mean magnitude and standard deviation of the 80 to 500
Hz frequency band in the group with the smallest mean
magnitude was considered noise and group differences
between mean magnitudes in this band only considered
significant if they exceeded three times the previously cal-
culated standard deviation.
The following describes the method by which the digi-
tised ensemble averaged alternate T wave vectors (X1, X2,
Y1, Y2, Z1 and Z2) were used to calculate the mean ATAs
for each group.
Time of T wave Analysis= t = 400 milliseconds
Subjects in groups 1 and 2 = 1 to N1 and 1 to N2
[Vector X1 - Vector X2]2 = Vector (DiffX)2
[Vector Y1 - Vector Y2]2 = Vector (DiffY)2
[Vector Z1 - Vector Z2]2 = Vector (DiffZ)2
Resultant Absolute Difference Vector (ATA) = √  (DiffX2 +
DiffY2 + DiffZ2)BMC Cardiovascular Disorders 2002, 2 http://www.biomedcentral.com/1471-2261/2/6
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Mean value of Group (1 or 2) mean ATA= [Group (1 or 2)
mean ATA]/t
Statistics
Two tailed t test was used to assess group differences be-
tween mean ATAs and intra and inter-group differences
between the first (0–133 milliseconds), second (134–237
milliseconds) and third mean ATA (238–400 millisec-
onds). The statistical group differences between the mag-
nitude of components within the 80 to 500 Hz band have
been described above.
Results
An example of the time aligned alternate sequences of ST-
T waves over 400 milliseconds duration is shown in figure
2. The mean value and standard deviation for each group
member ATA are shown in Table 1. There was no signifi-
cant difference between the means for groups 1 and 2
mean ATAs. The mean value and standard deviation for
group 1 v group 2 being 10.7 microvolts (standard devia-
tion= 7.17 microvolts) v 11.74 microvolts (standard devi-
ation= 8.48 microvolts) respectively. All the values for the
difference between ensemble averaged T waves for each
vector in each patient are shown in table 1. There was no
intra or inter-group significant difference in the mean val-
ues between the first, second or third time intervals for
each groups mean ATA. The mean values for first, second
and third intervals for Group 1 v Group 2 being 6.59 v
7.17, 6.37 v 7.96 and 6.06 v 6.18, respectively. The Power
Spectrum for each groups resultant absolute difference
vector between alternate sequences of ensemble averaged
ST-T waves showed the largest values between 0 and 25
Hertz with maximum significant differences at the mean
or DC frequency, see figures 3 and 4. The cross spectral
density function showed that both groups shared the
same frequency components, see figure 5. There was no
significant group differences between the mean magni-
tudes of frequency band 80–500 Hertz for Group 1 v
Group 2. The standard deviation in this band for Group 1
(noise) = 0.562, the mean magnitudes for Group 1 v
Group 2 in this band being 0.615 v 0.823.
Discussion
The purpose of this pilot study was to assess the ability of
the absolute measurements for the microvolt magnitude
of TA to differentiate between one group with an estab-
lished high risk of MA (Group2) versus a group of patients
with multiple physical substrates for developing MA but
without a history of a significant arrhythmic event (Group
1). Group 1 was chosen to be representative of those pa-
tients whom make up a large proportion of the inexorably
increasing coronary heart disease population and on clin-
ical criteria would theoretically be at highest risk from de-
veloping a MA and therefore most likely to benefit from
accurate risk stratification and defibrillator implantation.
It is important to scrutinise the limitations of any index
proffered to help risk stratification and aid the focussing
of limited resources of invasive electrophysiological inves-
tigation with a view to device therapy.
Assuming a standard error of approximately 6% for the
measurement of ejection fraction by acoustic quantifica-
tion method, the two groups had similar ejections frac-
tions and presumably similar degrees of post-infarction
ventricular damage. The lower ejection fraction of Group
1 would be compatible with the intended selection bias
Group1 mean ATA ATA N Group2 mean ATA ATA N2
NN 2
= () ( ) = () ( ) ∑∑ 1
1
1
1
Figure 1
Diagram showing methodology for sampling analog ECG sig-
nal in X, Y and Z leads in a rested, supine patient during
breath holding. 400 milliseconds of alternate T wave
sequences were ensemble averaged for each lead and col-
lected in matrix bins represented by X1, Y1, Z1 and X2, Y2
and Z2.BMC Cardiovascular Disorders 2002, 2 http://www.biomedcentral.com/1471-2261/2/6
Page 4 of 7
(page number not for citation purposes)
and the greater degree of scarring and contractile dysfunc-
tion function in this group. Both groups were stable in
terms of heart failure and the absence of dynamic sympto-
matic ischaemic syndromes, therefore the observed meas-
urements of TA in time and frequency domains are
expected to arise from mechanism associated with the
post myocardial infarction scarred tissue and it's immedi-
ate periphery.
Conventional TA indices either measure the alternans ra-
tio [11] which is the extent to which the measured altern-
ans exceeds the uncertainty (noise) of the measurement
and conveys the statistical degree of confidence in the al-
ternans measurement, or the cumulative alternans voltage
in microvolts, which is derived from the frequency power
spectrum and analogous, but not equivalent to resultant
vector of absolute difference in alternate T wave sequences
(ATA) used as the index in this study. The spectral method
is an indirect method which measures the magnitude of
TA as the amplitude of spectral power at the 0.5 cycles per
beat frequency and then subtracts the mean background
noise.
This method will not compensate for the presence of su-
perposed noise contamination of the 0.5 frequency com-
ponent amplitude which is then squared to derive the
power term. There is an assumption with the spectral
measurement method, that the noise is all broad band but
it may be non-linear or multiplicative and therefore not
eliminated by the spectral method of subtracting the
mean of the baseline noise. Perturbations to increase the
heart rate have been used to improve the signal to noise
ratio of the spectral method in order to improve the sen-
sitivity to detect significant TA. This study describes a di-
rect method which measures absolute TA which for
reasons described in the next paragraph has a high signal
to noise ratio. This may account for the higher mean val-
ues of ATA compared to the values of mean cumulative al-
ternans voltage which is circa 1.2 microvolts. As the index
ATA is an absolute measure of the alternating microvolt T
wave amplitude, what it conveys is more in faith with the
Figure 2
An example of two ensemble averaged, time aligned, alter-
nate 400 milliseconds of T wave sequences for lead X in sub-
ject 2. The x axis is in milliseconds and the y axis in
microvolts. The dashed and continuous tracings represent an
inverted T wave in this subject.
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Figure 3
Spectral analysis of the resultant vectored absolute mean TA
for the ischaemic cardiomyopathy group (group 1). The y
axis represents the magnitude of spectral components and
the x axis represents frequency in Hertz. Only the range
from 0 to 40 Hertz is shown for clarity.
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definition of TA. This pilot study demonstrates that the re-
sultant vector of absolute differences in TA microvoltage
measured as the index ATA, which was obtained from en-
semble averaged alternate T wave sequences during breath
holding, may demonstrate low specificity when applied to
the risk stratification in those post-infarction patients with
ischaemic cardiomyopathies. A recent study by Sakabe
and colleagues have demonstrated a specificity of only
35% in a prospective study using TA to predict the devel-
opment of ventricular tachycardia in non-ischaemic cardi-
omyopathy patients [16]. This paper supports our results
and has significant implications for the specificity of TA
when used as a discriminatory probe in the cardiomyopa-
thy patient subset.
Our method of measuring absolute TA minimises inaccu-
racies due to noise by ensemble averaging the data collect-
ed under optimal conditions of stability of the
electrocardiographic tracing by suspending respiration in
a supine rested patient. The noise remaining after ensem-
ble averaging is then largely eliminated by subtracting the
alternate ensemble averaged T wave signal sequences from
each other, thus subtracting the equal amounts of back-
ground noise within each of the sequences from each oth-
er. It is known that TA can be produced by motion of the
heart within the thoracic cavity, previous studies have not
addressed the augmentation of such motion with respira-
tion. It has been suggested that using a resultant vector of
orthogonal leads is sufficient to mitigate against the ef-
fects of mechanical rotation of the heart when measuring
TA [11] but theoretically the resultant vector will oscillate
with cardiac and respiratory motion. Data from long,
noisy, non-stationary ECG recordings, of the type found
in Holter recordings or during exercise, would add to in-
accuracies resulting from cardiac motion. We attempted
to correct for any such inaccuracy arising from respiration-
Figure 4
Spectral analysis of the resultant vectored absolute mean TA
for the implanted defibrillator group (group 2). The y axis
represents the magnitude of spectral components and the x
axis represents frequency in Hertz. Only the range from 0 to
40 Hertz is shown for clarity.
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Figure 5
Cross-Spectral analysis for the resultant vectored absolute
mean TA for both groups. The y axis is the magnitude of
cross-spectral frequency components and the x axis is in
Hertz. Note that all positive values indicate the presence of a
common frequency component between both groups with
expected large magnitudes in the frequency range between 0
to 40 Hertz.
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by suspending the respiration in half held breath. The
number of recordings of complexes was limited due to the
time over which the patients could comfortably breath-
hold but the accuracy of the measured absolute resultant
vector of microvolt TA in a limited number of complexes
was considered an advantage over a TA index compiled
from a more numerous but more variable and inaccurate
data source.
For both groups the absolute difference in mean ATA was
distributed equally in time throughout the ST-T wave,
which corresponds to the finding that the maximum dif-
ferences in frequency content for the ATAs in both groups
occur at the mean or dc frequency component but there
was also a significantly increased magnitude of ATA With-
in the 0–25 Hertz frequency band which would include
the T wave peak frequency and subharmonics within the
T wave. In the same way that spatial heterogeneities of de-
polarisation are responsible for the spectral component
markers of late potentials within the QRS complexes, Fou-
rier techniques were applied to the ST-T waves to deter-
mine the presence of any difference in the higher
frequency bands between alternating ST-T sequences
which may indicate the presence of alternating spatial het-
erogeneities of repolarisation. The finding of no statisti-
cally significant group differences in mean magnitude
within the frequency band 80 to 500 Hertz is compatible
with the findings of Steinbigler et al [15] and does not
provide a probe to differentiate these two groups. This
study only showed a significant difference in the mean fre-
quency of alternating sequences, which suggests that the
differences in measured alternating microvolt magnitudes
of the ST-T wave were not due to a change in the morphol-
ogy of the wave due to introduction of discrete frequency
components. The ATAs in the time domain also showed
homogenous distribution throughout the ST-T waves,
which implies that the origin of TA is not an anatomically
localised phenomena as it does not appear to arise from
the repolarisation gradient generated between the epicar-
dial, endocardial and M myocardial layers, which accord-
ing to Antzelevitch and colleagues correspond to the
epochs of the start of the peak T wave, the initial descend-
ing T wave and end of the descending T wave respectively
[17].
There is controversy as to whether TA indices show signif-
icant specificity when identifying patients with idiopathic
cardiomyopathy at high risk of ventricular arrhythmias
[14,16]. Alternatively, TA has been shown to be very use-
ful in identifying arrhythmic risk in the non-specific post
infarction population, where sensitivities and negative
predictive values are 93% and 98% respectively [13].
However, the major arrhythmic risk lies in the large post
infarction cardiomyopathy population but there has been
little focus on the use of TA markers in this specific sub-
group with coronary heart disease. On the basis of this pi-
lot study, larger scale studies are indicated with
electrophysiological ventricular stimulation as reference
standard to further assess the sensitivity and specificity of
absolute and spectral derived indices of TA to identify pa-
tients at high risk of MA within the population of post in-
farction ischaemic cardiomyopathic heart failure patients.
Conclusions
This pilot study did not show any significant difference in
the magnitude and distribution of absolute TA microvolt-
ages or spectral components between Groups 1 and 2.
Our results in ischaemic cardiomyopathy patients is sup-
ported by another study on cardiomyopathy subsets
which has shown a low specificity for TA to identify ar-
rhythmic risk. These results suggest larger scale studies are
needed.
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Table 1: Values of the squared microvolt differences between en-
semble averaged T waves meaned over time, in each patients X, 
Y and Z leads and values of each patients ATA. Patient numbers 
1 to 7 represent Group 1 and patient numbers 8 to 16 represent 
Group 2. Values < 0.015 rounded to 0.
XYZ A T A
1 304.85 0 72.76 19.43
20 0 0 0
3 144.96 0 94.67 15.48
42 4 . 6 0 0 4 . 9 6
5 38.8 55.65 0 9.72
6 4.6 44.62 7.07 7.5
7 192.93 32.26 91.58 17.8
8 143 278.9 0 20.05
9 2.16 2.16 17.5 4.67
10 40.57 0 6.66 6.87
11 186.6 0 0 13.66
12 57.5 31.92 33.9 11.1
13 0 0 0 0
14 0 17.3 0 4.16
15 225.6 291.7 9.36 22.9
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